{
     "PMID": "27468976",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20180112",
     "LR": "20180122",
     "IS": "1095-9327 (Electronic) 1044-7431 (Linking)",
     "VI": "75",
     "DP": "2016 Sep",
     "TI": "The absence of pleiotrophin modulates gene expression in the hippocampus in vivo and in cerebellar granule cells in vitro.",
     "PG": "113-21",
     "LID": "10.1016/j.mcn.2016.07.004 [doi] S1044-7431(16)30081-1 [pii]",
     "AB": "Pleiotrophin (PTN) is a secreted growth factor recently proposed to act as a neuromodulatory peptide in the Central Nervous System. PTN appears to be involved in neurodegenerative diseases and neural disorders, and it has also been implicated in learning and memory. Specifically, PTN-deficient mice exhibit a lower threshold for LTP induction in the hippocampus, which is attenuated in mice overexpressing PTN. However, there is little information about the signaling systems recruited by PTN to modulate neural activity. To address this issue, the gene expression profile in hippocampus of mice lacking PTN was analyzed using microarrays of 22,000 genes. In addition, we corroborated the effect of the absence of PTN on the expression of these genes by silencing this growth factor in primary neuronal cultures in vitro. The microarray analysis identified 102 genes that are differentially expressed (z-score>3.0) in PTN null mice, and the expression of eight of those modified in the hippocampus of KO mice was also modified in vitro after silencing PTN in cultured neurons with siRNAs. The data obtained indicate that the absence of PTN affects AKT pathway response and modulates the expression of genes related with neuroprotection (Mgst3 and Estrogen receptor 1, Ers 1) and cell differentiation (Caspase 6, Nestin, and Odz4), both in vivo and in vitro.",
     "CI": [
          "Copyright (c) 2016 Elsevier Inc. All rights reserved."
     ],
     "FAU": [
          "Gonzalez-Castillo, Celia",
          "Ortuno-Sahagun, Daniel",
          "Guzman-Brambila, Carolina",
          "Marquez-Aguirre, Ana Laura",
          "Raisman-Vozari, Rita",
          "Pallas, Merce",
          "Rojas-Mayorquin, Argelia E"
     ],
     "AU": [
          "Gonzalez-Castillo C",
          "Ortuno-Sahagun D",
          "Guzman-Brambila C",
          "Marquez-Aguirre AL",
          "Raisman-Vozari R",
          "Pallas M",
          "Rojas-Mayorquin AE"
     ],
     "AD": "Doctorado en Ciencias en Biologia Molecular en Medicina (DCBMM), CUCS, Universidad de Guadalajara, Jalisco, Mexico. Instituto de Investigacion en Ciencias Biomedicas (IICB), CUCS, Universidad de Guadalajara, Jalisco, Mexico. Electronic address: dortuno@cucs.udg.mx. Tecnologico de Monterrey, Division de Biotecnologia y Salud, Escuela de Medicina, Campus Guadalajara, Jalisco, Mexico. Unidad de Biotecnologia Medica y Farmaceutica, Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco A.C., 44270 Guadalajara, Jalisco, Mexico. Sorbonne Universite UPMC UM75 INSERM U1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle Epiniere, Paris, France. Department of Pharmacology and Medical Chemistry, Faculty of Pharmacy, Institute of Neuroscience (INUB), Centros de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED), University of Barcelona, Spain. Departamento de Ciencias Ambientales, Instituto de Neurociencias, CUCBA, Universidad de Guadalajara, Jalisco, Mexico. Electronic address: argelia.rojas@academicos.udg.mx.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20160726",
     "PL": "United States",
     "TA": "Mol Cell Neurosci",
     "JT": "Molecular and cellular neurosciences",
     "JID": "9100095",
     "RN": [
          "0 (Carrier Proteins)",
          "0 (Cytokines)",
          "0 (RNA, Ribosomal, 18S)",
          "0 (Synaptophysin)",
          "134034-50-7 (pleiotrophin)",
          "EC 2.7.11.1 (Proto-Oncogene Proteins c-akt)",
          "EC 2.7.11.24 (JNK Mitogen-Activated Protein Kinases)",
          "EC 3.4.22.- (Caspase 6)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Carrier Proteins/genetics/*metabolism",
          "Caspase 6/genetics/metabolism",
          "Cells, Cultured",
          "Cerebellum/cytology/*metabolism",
          "Cytokines/deficiency/genetics/*metabolism",
          "Hippocampus/cytology/*metabolism",
          "JNK Mitogen-Activated Protein Kinases/genetics/metabolism",
          "Male",
          "Mice",
          "Mice, Inbred C57BL",
          "Neurons/*metabolism",
          "Proto-Oncogene Proteins c-akt/metabolism",
          "RNA, Ribosomal, 18S/genetics/metabolism",
          "Rats",
          "Rats, Sprague-Dawley",
          "Signal Transduction",
          "Synaptophysin/genetics/metabolism",
          "*Transcriptome"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "*AKT",
          "*Caspase 6",
          "*Cerebellar granule cells",
          "*Gene expression",
          "*Hippocampus",
          "*Neuromodulation",
          "*Pleiotrophin"
     ],
     "EDAT": "2016/07/30 06:00",
     "MHDA": "2018/01/13 06:00",
     "CRDT": [
          "2016/07/30 06:00"
     ],
     "PHST": [
          "2015/06/19 00:00 [received]",
          "2016/07/04 00:00 [revised]",
          "2016/07/25 00:00 [accepted]",
          "2016/07/30 06:00 [entrez]",
          "2016/07/30 06:00 [pubmed]",
          "2018/01/13 06:00 [medline]"
     ],
     "AID": [
          "S1044-7431(16)30081-1 [pii]",
          "10.1016/j.mcn.2016.07.004 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Mol Cell Neurosci. 2016 Sep;75:113-21. doi: 10.1016/j.mcn.2016.07.004. Epub 2016 Jul 26.",
     "term": "hippocampus"
}